NCT01209195: A Study of MM-121 in Combination With Paclitaxel in Patients With Advanced Gynecologic and Breast Cancers |
|
|
| Completed | 1 | 41 | US | MM-121, Seribantumab, SAR256212, Paclitaxel, Taxol | Merrimack Pharmaceuticals, Sanofi | Locally Advanced/Metastatic or Recurrent Ovarian Cancer, Fallopian Tube Cancer,, Primary Peritoneal Cancer or Endometrial Cancer, Locally Advanced/Metastatic Her2 Non Overexpressing Breast Cancer | 05/14 | 07/14 | | |